EGFR and triple-negative breast carcinoma: For example, the CL4 aptamer inhibits the growth of triple negative breast cancer (TNBC) cells by impairing binding of epidermal growth factor receptor (EGFR) to integrin αvβ3 (Camorani et al., 2017).